What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
16/08/2024
Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der italienischen Behörde mitgeteilt, dass in Italien, zusätzlich zu den bereits bekannt gegebenen Provinzen, in Novara (Region Piemont) die ID WNV NAT Testung für Spenden von Blut und Blutkomponenten eingeführt wurde.
Referenced at:
Bumetanide New
PRAC signal recommendation
|
14/08/2024
Risko for toxic epidermal necrolysis and Stevens-Johnson syndrome. Further information and amendments to the product information can be found on the EMA website.
Acetazolamide New
PRAC signal recommendation
|
14/08/2024
Pulmonary oedemas. Further information and amendments to the product information can be found on the EMA website.
Minoxidil (topical formulation) New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Clevidipine New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Nimodipine New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Ceftazidime New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Buprenorphine/Naloxone New
PSUR-outcome
|
06/08/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Buprenorphine (all formulations except implants) New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Teriflunomide New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.